Crispr Gene Editing Etf Xdna

Kelly Intel Founder & CEO Kevin Kelly joins Jill Malandrino on Nasdaq #TradeTalks to discuss $XDNA an ETF that seeks to capture the next generation of healthcare by investing in companies leading the CRISPR and gene editing revolution.

#nasdaq #stockmarket #stocks #finance #financial #trading #trader #stock